CRISPR

CRISPR1-wfs1a

ID
ZDB-CRISPR-261013-8
Name
CRISPR1-wfs1a
Previous Names
None
Target
Sequence
5' - GGATAATAGTGCTCAGCCAC - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
The PAM site was "TGG" at the 3' end.
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
ah829 wfs1a
Expression
Gene expression in Wild Types + CRISPR1-wfs1a
No data available
Phenotype
Phenotype resulting from CRISPR1-wfs1a
No data available
Phenotype of all Fish created by or utilizing CRISPR1-wfs1a
Phenotype Fish Conditions Figures
whole organism Ab13-mbp labeling decreased amount, abnormal wfs1aah829/ah829; wfs1bah828/ah828 (AB) standard conditions Figure 3 with image from Tang et al., 2026
whole organism hmgcs1 expression decreased amount, abnormal wfs1aah829/ah829; wfs1bah828/ah828 (AB) standard conditions Figure 4 with image from Tang et al., 2026
whole organism mag expression decreased amount, abnormal wfs1aah829/ah829; wfs1bah828/ah828 (AB) standard conditions Figure 3 with image from Tang et al., 2026
swimming behavior decreased process quality, abnormal wfs1aah829/ah829; wfs1bah828/ah828 (AB) standard conditions Figure 1 with image from Tang et al., 2026
Mauthner neuron axon increased ratio oligodendrocyte myelin sheath, abnormal wfs1aah829/ah829; wfs1bah828/ah828 (AB) standard conditions Figure 3 with image from Tang et al., 2026
whole organism plp1b expression decreased amount, abnormal wfs1aah829/ah829; wfs1bah828/ah828 (AB) standard conditions Figure 3 with image from Tang et al., 2026
eye decreased area, abnormal wfs1aah829/ah829; wfs1bah828/ah828 (AB) standard conditions Figure 1 with image from Tang et al., 2026
whole organism mpz expression decreased amount, abnormal wfs1aah829/ah829; wfs1bah828/ah828 (AB) standard conditions Figure 3 with image from Tang et al., 2026
heart heart contraction decreased rate of continuous process, abnormal wfs1aah829/ah829; wfs1bah828/ah828 (AB) standard conditions Figure 1 with image from Tang et al., 2026
whole organism Ab1-hmgcs1 labeling decreased amount, abnormal wfs1aah829/ah829; wfs1bah828/ah828 (AB) standard conditions Figure 4 with image from Tang et al., 2026
whole organism mbpa expression decreased amount, abnormal wfs1aah829/ah829; wfs1bah828/ah828 (AB) standard conditions Figure 3 with image from Tang et al., 2026
whole organism Ab38-gapdh labeling decreased amount, abnormal wfs1aah829/ah829; wfs1bah828/ah828 (AB) standard conditions Figure 4 with image from Tang et al., 2026
oligodendrocyte decreased amount, abnormal wfs1aah829/ah829; wfs1bah828/ah828; vu12Tg (AB) standard conditions Figure 2 with image,  Figure 6 with image from Tang et al., 2026
oligodendrocyte amount, ameliorated wfs1aah829/ah829; wfs1bah828/ah828; vu12Tg (AB) chemical treatment by injection: geranylgeraniol Figure 6 with image from Tang et al., 2026
oligodendrocyte mpz expression decreased amount, abnormal wfs1aah829/ah829; wfs1bah828/ah828; vu12Tg (AB) standard conditions Figure 5 with image from Tang et al., 2026
oligodendrocyte hmgcs1 expression decreased amount, abnormal wfs1aah829/ah829; wfs1bah828/ah828; vu12Tg (AB) standard conditions Figure 5 with image from Tang et al., 2026
oligodendrocyte mbpa expression decreased amount, abnormal wfs1aah829/ah829; wfs1bah828/ah828; vu12Tg (AB) standard conditions Figure 5 with image from Tang et al., 2026
oligodendrocyte plp1b expression decreased amount, abnormal wfs1aah829/ah829; wfs1bah828/ah828; vu12Tg (AB) standard conditions Figure 5 with image from Tang et al., 2026
oligodendrocyte mag expression decreased amount, abnormal wfs1aah829/ah829; wfs1bah828/ah828; vu12Tg (AB) standard conditions Figure 5 with image from Tang et al., 2026
Citations